{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:18:18Z","timestamp":1789802298570,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107290","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:49:05Z","timestamp":1758772145000},"page":"107290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Population pharmacokinetics of mycophenolic acid and Bayesian estimator in lung transplant adults recipients in the early post-transplant period"],"prefix":"10.1016","volume":"214","author":[{"given":"Juliette","family":"Kauv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Feuillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Barrail-Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Delemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Verstuyft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Le Pavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Comets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-3458","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejps.2025.107290_bib0001","doi-asserted-by":"crossref","first-page":"1097\u20111106","DOI":"10.1007\/s00228-014-1709-7","article-title":"Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins","volume":"70","author":"Barnes","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107290_bib0002","doi-asserted-by":"crossref","first-page":"295\u2011311","DOI":"10.1002\/jcph.1565","article-title":"Mycophenolic Acid and Its Pharmacokinetic Drug-Drug Interactions in Humans : Review of the Evidence and Clinical Implications","volume":"60","author":"Benjanuwattra","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107290_bib0003","doi-asserted-by":"crossref","first-page":"150\u2011200","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized Therapy for Mycophenolate : Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.ejps.2025.107290_bib0004","doi-asserted-by":"crossref","first-page":"1745\u20111751","DOI":"10.1002\/lt.21607","article-title":"Comparison of a new enzymatic assay with a high-performance liquid chromatography\/ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients","volume":"14","author":"Blanchet","year":"2008","journal-title":"Liver Transplant.: Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"10","key":"10.1016\/j.ejps.2025.107290_bib0005","doi-asserted-by":"crossref","first-page":"1042\u20111055","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation : Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J. Heart Lung Transplant.: Off. Publ. Int. Soc. Heart Transplant."},{"issue":"19","key":"10.1016\/j.ejps.2025.107290_bib0006","doi-asserted-by":"crossref","first-page":"1822\u20111836","DOI":"10.1056\/NEJMra2401039","article-title":"Lung Transplantation","volume":"391","author":"Christie","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejps.2025.107290_bib0007","doi-asserted-by":"crossref","first-page":"479\u2011482","DOI":"10.1111\/j.1365-2125.2004.02326.x","article-title":"Raloxifene pharmacokinetics in males with normal and impaired renal function","volume":"59","author":"Czock","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0008","doi-asserted-by":"crossref","first-page":"29\u201139","DOI":"10.2165\/11594050-000000000-00000","article-title":"Bayesian Estimation of Mycophenolate Mofetil in Lung Transplantation, Using a Population Pharmacokinetic Model Developed in Kidney and Lung Transplant Recipients","volume":"51","author":"de Winter","year":"2012","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ejps.2025.107290_bib0009","doi-asserted-by":"crossref","first-page":"893\u2011907","DOI":"10.1111\/j.1365-2125.2008.03109.x","article-title":"Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9","volume":"65","author":"Jiao","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0010","doi-asserted-by":"crossref","first-page":"7\u201116","DOI":"10.1592\/phco.29.1.7","article-title":"Pharmacokinetics of Mycophenolic Acid in Patients with Lupus Nephritis","volume":"29","author":"Joy","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.ejps.2025.107290_bib0011","doi-asserted-by":"crossref","first-page":"547\u2011558","DOI":"10.1007\/s40262-017-0593-6","article-title":"Population Pharmacokinetics of Mycophenolic Acid : An Update","volume":"57","author":"Kiang","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.ejps.2025.107290_bib0012","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/TP.0b013e3181744199","article-title":"Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review","volume":"85","author":"Knight","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0013","doi-asserted-by":"crossref","first-page":"83\u201192","DOI":"10.1007\/s00228-023-03587-0","article-title":"Limited sampling strategy and population pharmacokinetic model of mycophenolic acid in pediatric patients with systemic lupus erythematosus : Application of a double gamma absorption model with SAEM algorithm","volume":"80","author":"Koloskoff","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107290_bib0014","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/pharmaceutics13081191","article-title":"External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab","volume":"13","author":"Konecki","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejps.2025.107290_bib0015","doi-asserted-by":"crossref","first-page":"253\u2011266","DOI":"10.2165\/00003088-200443040-00004","article-title":"Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Concentrations in Stable Renal Transplant Patients","volume":"43","author":"Le Guellec","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2025.107290_bib0016","doi-asserted-by":"crossref","unstructured":"Le Meur, Y., Borrows, R., Pescovitz, M. D., Budde, K., Grinyo, J., Bloom, R., Gaston, R., Walker, R. G., Kuypers, D., van Gelder, T., & Kiberd, B. (2011). Therapeutic drug monitoring of mycophenolates in kidney transplantation: Report of The Transplantation Society consensus meeting. Transplant. Rev., 25(2), 58\u201164. https:\/\/doi.org\/10.1016\/j.trre.2011.01.002.","DOI":"10.1016\/j.trre.2011.01.002"},{"issue":"9","key":"10.1016\/j.ejps.2025.107290_bib0017","doi-asserted-by":"crossref","first-page":"604\u2011612","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ejps.2025.107290_bib0018","doi-asserted-by":"crossref","first-page":"319\u2011330","DOI":"10.2165\/11598930-000000000-00000","article-title":"The relationship between drug clearance and body size : Systematic review and meta-analysis of the literature published from 2000 to 2007","volume":"51","author":"McLeay","year":"2012","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.ejps.2025.107290_bib0019","first-page":"2496\u20112503","article-title":"Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation","volume":"7","author":"Meur","year":"2007","journal-title":"Am. J. TransPlant"},{"issue":"8","key":"10.1016\/j.ejps.2025.107290_bib0020","doi-asserted-by":"crossref","first-page":"489\u2011516","DOI":"10.2165\/11317240-000000000-00000","article-title":"Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation : Part II","volume":"48","author":"Monchaud","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0021","doi-asserted-by":"crossref","first-page":"88\u201194","DOI":"10.1093\/clinchem\/47.1.88","article-title":"Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil","volume":"47","author":"Mourad","year":"2001","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.ejps.2025.107290_bib0022","doi-asserted-by":"crossref","first-page":"1291\u20111302","DOI":"10.1007\/s40262-021-01037-7","article-title":"The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid : Systematic Review and Meta-analysis","volume":"60","author":"Na Takuathung","year":"2021","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.ejps.2025.107290_bib0023","doi-asserted-by":"crossref","first-page":"4732\u20114741","DOI":"10.1111\/bcp.15389","article-title":"Population pharmacokinetics and Bayesian estimation of mycophenolate mofetil in patients with autoimmune hepatitis","volume":"88","author":"Nanga","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107290_bib0024","doi-asserted-by":"crossref","first-page":"898\u2011903","DOI":"10.1038\/clpt.2008.59","article-title":"Emerging evidence of the impact of kidney disease on drug metabolism and transport","volume":"83","author":"Nolin","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107290_bib0025","first-page":"273\u2011284","article-title":"Acute postoperative management after lung transplantation","volume":"31","author":"Potestio","year":"2017"},{"issue":"9","key":"10.1016\/j.ejps.2025.107290_bib0026","doi-asserted-by":"crossref","first-page":"1067\u20111077","DOI":"10.1177\/0961203320931567","article-title":"Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis","volume":"29","author":"Romano-Aguilar","year":"2020","journal-title":"Lupus."},{"issue":"2","key":"10.1016\/j.ejps.2025.107290_bib0027","doi-asserted-by":"crossref","first-page":"267\u2011279","DOI":"10.1093\/toxsci\/kfz231","article-title":"Mechanisms of Metabolism Interaction Between p-Cresol and Mycophenolic Acid","volume":"173","author":"Rong","year":"2020","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"issue":"9","key":"10.1016\/j.ejps.2025.107290_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms160920168","article-title":"Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation","volume":"16","author":"Ruiz","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2025.107290_bib0029","doi-asserted-by":"crossref","first-page":"594\u2011605","DOI":"10.1097\/FTD.0b013e3181ee52e2","article-title":"Population Pharmacokinetics of Mycophenolic Acid and Metabolites in Patients With Glomerulonephritis","volume":"32","author":"Sam","year":"2010","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0030","doi-asserted-by":"crossref","first-page":"1\u201124","DOI":"10.2165\/11536640-000000000-00000","article-title":"The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease","volume":"50","author":"Sherwin","year":"2011","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0031","doi-asserted-by":"crossref","first-page":"13\u201158","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejps.2025.107290_bib0032","doi-asserted-by":"crossref","first-page":"148\u2011151","DOI":"10.1097\/FTD.0b013e3182a8eea9","article-title":"Mycophenolic acid pharmacokinetics in lung transplant recipients with cystic fibrosis","volume":"36","author":"Stuckey","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.ejps.2025.107290_bib0033","first-page":"407\u2011417","article-title":"Limited Sampling Strategy for the Estimation of Mycophenolic Acid and its Acyl Glucuronide Metabolite Area under the Concentration-Time Curve in Japanese Lung Transplant Recipients","volume":"22","author":"Tanaka","year":"2019","journal-title":"J. Pharm. Pharm. Sci.: Publ. Can. Soc. Pharm. Sci. Soc. Can. Sci. Pharm."},{"issue":"9","key":"10.1016\/j.ejps.2025.107290_bib0034","doi-asserted-by":"crossref","first-page":"1232\u20111240","DOI":"10.1592\/phco.26.9.1232","article-title":"Limited Sampling Strategy for Predicting Area Under the Concentration-Time Curve of Mycophenolic Acid in Adult Lung Transplant Recipients","volume":"26","author":"Ting","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.ejps.2025.107290_bib0035","doi-asserted-by":"crossref","first-page":"261\u2011266","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"van Gelder","year":"1999","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ejps.2025.107290_bib0036","doi-asserted-by":"crossref","first-page":"673\u2011679","DOI":"10.1007\/s00228-015-1854-7","article-title":"Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis","volume":"71","author":"Wang","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107290_bib0037","doi-asserted-by":"crossref","first-page":"697\u2011704","DOI":"10.1080\/00498254.2016.1214885","article-title":"Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis","volume":"47","author":"Wang","year":"2017","journal-title":"Xenobiotica"},{"issue":"12","key":"10.1016\/j.ejps.2025.107290_bib0038","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14088","article-title":"Plasma mycophenolic acid concentration and the clinical outcome after lung transplantation","volume":"34","author":"Yabuki","year":"2020","journal-title":"Clin. TransPlant"},{"issue":"11","key":"10.1016\/j.ejps.2025.107290_bib0039","doi-asserted-by":"crossref","first-page":"1566\u20111579","DOI":"10.1038\/aps.2017.115","article-title":"Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients","volume":"38","author":"Yu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.ejps.2025.107290_bib0040","doi-asserted-by":"crossref","first-page":"746\u2011761","DOI":"10.1111\/bcp.13850","article-title":"Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus","volume":"85","author":"Zhang","year":"2019","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872500288X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872500288X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:40:38Z","timestamp":1767800438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872500288X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"alternative-id":["S092809872500288X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107290","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of mycophenolic acid and Bayesian estimator in lung transplant adults recipients in the early post-transplant period","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107290"}}